Resistant Hypertension and Related Outcomes in a Cohort of Patients with Cardiorenal Multimorbidity Hospitalized in an Internal Medicine Ward-Reference-Cited by-同舟云学术

Resistant Hypertension and Related Outcomes in a Cohort of Patients with Cardiorenal Multimorbidity Hospitalized in an Internal Medicine Ward

Published:2023-11-27 Issue:6 Volume:30 Page:585-590
ISSN:1179-1985
Container-title:High Blood Pressure & Cardiovascular Prevention
language:en
Short-container-title:High Blood Press Cardiovasc Prev

Author:

Gigante Antonietta^ORCID,Cianci Rosario,Brigato Claudia,Melena Michele,Acquaviva Erika,Toccini Ludovica,Pellicano Chiara,Rosato Edoardo,Muscaritoli Maurizio

Funder

Università degli Studi di Roma La Sapienza

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40292-023-00609-x.pdf

Reference26 articles.

1. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023. https://doi.org/10.1097/HJH.0000000000003480.

2. Romano S, Rigon G, Albrigi M, Tebaldi G, Sartorio A, Cristin L, Burrei G, Fava C, Minuz P. Hypertension, uncontrolled hypertension and resistant hypertension: prevalence, comorbidities and prescribed medications in 228,406 adults resident in urban areas. A population-based observational study. Intern Emerg Med. 2023;18(7):1951–9. https://doi.org/10.1007/s11739-023-03376-8.

3. Romano S, Idolazzi C, Fava C, Fondrieschi L, Celebrano M, Delva P, Branz L, Donato A, Dalbeni A, Minuz P. Prevalence and comorbidities of resistant hypertension: a collaborative population-based observational study. High Blood Press Cardiovasc Prev. 2018;25(3):295–301. https://doi.org/10.1007/s40292-018-0268-x.

4. Noubiap JJ, Nansseu JR, Nyaga UF, Sime PS, Francis I, Bigna JJ. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart. 2019;105(2):98–105. https://doi.org/10.1136/heartjnl-2018-313599.

5. de Souza F, Muxfeldt ES, Salles GF. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management. Expert Rev Cardiovasc Ther. 2012;10(6):735–45. https://doi.org/10.1586/erc.12.58.